News · Chosun Biz·

'First domestic insulin pump' EOFlow wins ground in US litigation, but management normalization remains murky

Predicted impact: Medium

Favorable US litigation ruling, but earlier lawsuit news and convertible issuance already reported; restructuring still uncertain.

Comments

Sign in to comment

No comments yet. Start the conversation.

Comments are people's own views. Nothing here is financial advice.